In vivo dual-axis confocal microscopy of 5-ALA-induced PpIX to guide low-grade glioma resections
5-ALA 诱导的 PpIX 体内双轴共聚焦显微镜指导低级别胶质瘤切除
基本信息
- 批准号:10407972
- 负责人:
- 金额:$ 53.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAminolevulinic AcidAreaBiologicalBiophotonicsChildClinicalClinical ResearchCollectionComputer softwareConfocal MicroscopyDataDevicesDiffuseDiseaseEngineeringExcisionFDA approvedFluorescenceFutureGliomaHistologyImageImage AnalysisImage-Guided SurgeryImaging TechniquesImaging technologyImmunohistochemistryInstitutesLocationMachine LearningMagnetic Resonance ImagingMechanicsMethodsMicroscopeMicroscopicMicroscopyMolecularNatureNeurologicNeuronavigationOperative Surgical ProceduresOpticsOutcomePathologistPatient-Focused OutcomesPatientsPatternPerformancePostoperative PeriodProceduresProgression-Free SurvivalsProliferation MarkerPublic HealthQuality of lifeRandomizedRecurrenceReportingResidual stateResolutionS-Phase FractionSamplingSampling BiasesSpecimenSpeedSterilitySurgeonSurgical marginsTechniquesTechnologyTimeTissuesTrainingTumor BurdenValidationautomated algorithmbasebrain tissueclinically relevantdesignfluorescence-guided surgeryhigh resolution imagingimage guidedimage processingimaging modalityimprovedin vivoindustry partnerinnovationinstrumentationlensmicroscopic imagingneoplastic celloverexpressionprototyperadiological imagingsurvival outcometumor
项目摘要
Summary
Extent-of-resection is correlated with glioma patient outcomes such as progression-free survival. Image-
guidance technologies, based on MRI and now fluorescence-guided surgery (FGS), have been developed to
improve the surgeon’s ability to visualize gross tumor margins. However, there are fundamental limitations to
wide-field imaging methods such as MRI and FGS, such as poor sensitivity to detect disseminated tumor cells
at the infiltrative margins of diffuse gliomas, as well as the non-quantitative and subjective nature of image
interpretation. With the emergence of FGS using 5-ALA, and its recent approval by the FDA in 2017, the gap
between low-grade glioma (LGG) and high-grade glioma (HGG) patients, in terms of extent of resection, will
likely widen since LGGs rarely generate sufficient PpIX fluorescence to be detected via wide-field FGS.
Consequently, there is a clear need for improved intraoperative techniques with the sensitivity to detect and
quantify residual LGGs at the margins of the tumor cavity in order to improve the extent of resection and delay
recurrence. We have shown that high-resolution confocal microscopy has the sensitivity to visualize the sparse
sub-cellular expression of PpIX in LGG patients treated with 5-ALA, even beyond the radiographic margins.
Therefore, we will optimize a handheld optical-sectioning microscope to image 5-ALA-induced PpIX at the final
resection margins in LGG patients, together with real-time video mosaicking to facilitate the imaging of large
tissue areas, which will minimize sampling bias when imaging heterogeneous brain tissues (Aim 1). In order to
facilitate the clinical acceptance of these techniques, we will establish a relationship between the microscopic
patterns of PpIX expression and well-established biological metrics such as tumor burden and proliferative index
(Aim 2). Finally, we will explore the hypothesis that quantitative microscopic imaging of PpIX of the resection
margins is predictive of extent of resection, as currently defined by post-operative MRI, which would suggest that
it has value for optimizing resections to minimize and/or delay recurrence (Aim 3). Collectively, these results
will pave the way for future randomized controlled clinical studies to optimize resection procedures and outcomes
for LGG patients (adults and children), many of whom can have good survival outcomes and quality of life.
总结
切除范围与胶质瘤患者的预后相关,如无进展生存期。图像-
基于MRI和现在的荧光引导手术(FGS)的引导技术已经发展到
提高外科医生观察肿瘤边缘的能力。然而,有基本的限制,
宽视野成像方法如MRI和FGS等检测播散性肿瘤细胞的敏感性差
在弥漫性胶质瘤的浸润边缘,以及图像的非定量和主观性质,
解释。随着使用5-ALA的FGS的出现,以及FDA最近在2017年的批准差距
低级别胶质瘤(LGG)和高级别胶质瘤(HGG)患者之间,就切除范围而言,
可能加宽,因为LGG很少产生足够的PpIX荧光以通过宽场FGS检测。
因此,显然需要改进的术中技术,其具有检测和治疗肿瘤的灵敏度。
量化肿瘤腔边缘的残留LGG,以改善切除范围和延迟
复发我们已经表明,高分辨率共聚焦显微镜具有可视化稀疏的敏感性,
用5-ALA治疗的LGG患者中PpIX的亚细胞表达,甚至超过放射学边缘。
因此,我们将优化一个手持光学切片显微镜,以成像5-ALA诱导的PpIX在最后
LGG患者的切除边缘,以及实时视频马赛克,以促进大型肿瘤的成像
组织区域,这将在对异质脑组织成像时最大限度地减少采样偏差(目标1)。为了
为了促进这些技术的临床接受,我们将建立显微镜之间的关系,
PpIX表达模式和已确立的生物学指标,如肿瘤负荷和增殖指数
(Aim 2)。最后,我们将探讨假设,定量显微成像PpIX的切除
切缘可预测切除范围,如目前术后MRI所定义,这表明,
它对于优化切除以最小化和/或延迟复发(目标3)具有价值。总的来说,这些结果
将为未来的随机对照临床研究铺平道路,以优化切除手术和结局
对于LGG患者(成人和儿童),其中许多人可以有良好的生存结果和生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan T.C. Liu其他文献
Artificial Intelligence–Triaged 3-Dimensional Pathology to Improve Detection of Esophageal Neoplasia While Reducing Pathologist Workloads
人工智能——分层三维病理学以提高食管肿瘤的检测,同时减少病理学家的工作量
- DOI:
10.1016/j.modpat.2023.100322 - 发表时间:
2023-12-01 - 期刊:
- 影响因子:5.500
- 作者:
Lindsey A. Erion Barner;Gan Gao;Deepti M. Reddi;Lydia Lan;Wynn Burke;Faisal Mahmood;William M. Grady;Jonathan T.C. Liu - 通讯作者:
Jonathan T.C. Liu
Trends and Challenges for the Clinical Adoption of Fluorescence-Trends and Challenges for the Clinical Adoption of Fluorescence-Guided Surgery Guided Surgery
荧光引导手术临床采用的趋势和挑战-荧光引导手术临床采用的趋势和挑战 引导手术
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Jonathan T.C. Liu;Nader Sanai - 通讯作者:
Nader Sanai
Jonathan T.C. Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan T.C. Liu', 18)}}的其他基金
Prostate cancer risk stratification via computational 3D pathology
通过计算 3D 病理学进行前列腺癌风险分层
- 批准号:
10647788 - 财政年份:2022
- 资助金额:
$ 53.94万 - 项目类别:
Prostate cancer risk stratification via computational 3D pathology
通过计算 3D 病理学进行前列腺癌风险分层
- 批准号:
10459767 - 财政年份:2022
- 资助金额:
$ 53.94万 - 项目类别:
Instrumentation platform for 3D pathology with open-top light-sheet microscopy
具有开顶光片显微镜的 3D 病理学仪器平台
- 批准号:
10434718 - 财政年份:2021
- 资助金额:
$ 53.94万 - 项目类别:
Instrumentation platform for 3D pathology with open-top light-sheet microscopy
具有开顶光片显微镜的 3D 病理学仪器平台
- 批准号:
10178401 - 财政年份:2021
- 资助金额:
$ 53.94万 - 项目类别:
Instrumentation platform for 3D pathology with open-top light-sheet microscopy
具有开顶光片显微镜的 3D 病理学仪器平台
- 批准号:
10630094 - 财政年份:2021
- 资助金额:
$ 53.94万 - 项目类别:
In vivo dual-axis confocal microscopy of 5-ALA-induced PpIX to guide low-grade glioma resections
5-ALA 诱导的 PpIX 体内双轴共聚焦显微镜指导低级别胶质瘤切除
- 批准号:
10684738 - 财政年份:2020
- 资助金额:
$ 53.94万 - 项目类别:
Intraoperative confocal microscopy for quantitative delineation of low-grade glio
术中共聚焦显微镜定量描绘低级别胶质细胞
- 批准号:
9118107 - 财政年份:2014
- 资助金额:
$ 53.94万 - 项目类别:
Intraoperative confocal microscopy for quantitative delineation of low-grade glio
术中共聚焦显微镜定量描绘低级别胶质细胞
- 批准号:
8696044 - 财政年份:2014
- 资助金额:
$ 53.94万 - 项目类别:
Intraoperative confocal microscopy for quantitative delineation of low-grade glio
术中共聚焦显微镜定量描绘低级别胶质细胞
- 批准号:
8890436 - 财政年份:2014
- 资助金额:
$ 53.94万 - 项目类别:
Endoscopic molecular imaging of esophageal cancer with multiplexed Raman nanopart
使用多重拉曼纳米部件对食管癌进行内窥镜分子成像
- 批准号:
8283324 - 财政年份:2013
- 资助金额:
$ 53.94万 - 项目类别:
相似海外基金
Development of highly accurate diagnostic method using photodynamic diagnosis of aminolevulinic acid for lung cancer pleural disseminated lesions
氨基乙酰丙酸光动力诊断肺癌胸膜播散性病变高精度诊断方法的开发
- 批准号:
23K08286 - 财政年份:2023
- 资助金额:
$ 53.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme
使用 MRI 引导聚焦超声联合 5-氨基乙酰丙酸的声动力疗法治疗复发性多形性胶质母细胞瘤
- 批准号:
10699858 - 财政年份:2023
- 资助金额:
$ 53.94万 - 项目类别:
An optimized detection system for lung malignancies using 5-aminolevulinic acid.
使用 5-氨基乙酰丙酸的优化肺部恶性肿瘤检测系统。
- 批准号:
22K09011 - 财政年份:2022
- 资助金额:
$ 53.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment
荧光引导肿瘤切除和治疗中氨基乙酰丙酸-原卟啉 IX 的优化
- 批准号:
10818914 - 财政年份:2022
- 资助金额:
$ 53.94万 - 项目类别:
MEK PATHWAY INHIBITION COMBINED WITH 5-AMINOLEVULINIC ACID-PHOTODYNAMIC THERAPY FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA
MEK 通路抑制联合 5-氨基酮戊酸光动力疗法治疗弥漫性中线胶质瘤
- 批准号:
10733440 - 财政年份:2022
- 资助金额:
$ 53.94万 - 项目类别:
Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment
荧光引导肿瘤切除和治疗中氨基乙酰丙酸-原卟啉 IX 的优化
- 批准号:
10360122 - 财政年份:2022
- 资助金额:
$ 53.94万 - 项目类别:
MEK PATHWAY INHIBITION COMBINED WITH 5-AMINOLEVULINIC ACID-PHOTODYNAMIC THERAPY FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA
MEK 通路抑制联合 5-氨基酮戊酸光动力疗法治疗弥漫性中线胶质瘤
- 批准号:
10536455 - 财政年份:2022
- 资助金额:
$ 53.94万 - 项目类别:
Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment
荧光引导肿瘤切除和治疗中氨基乙酰丙酸-原卟啉 IX 的优化
- 批准号:
10705406 - 财政年份:2022
- 资助金额:
$ 53.94万 - 项目类别:
Exploratory study to demonstrate the usefulness of 5-aminolevulinic acid for biliary malignancy
探索性研究证明 5-氨基乙酰丙酸治疗胆道恶性肿瘤的有效性
- 批准号:
20K09071 - 财政年份:2020
- 资助金额:
$ 53.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sonodynamic therapy of soft tissue sarcoma with ultrasound using 5-Aminolevulinic acid (5-ALA)
使用 5-氨基乙酰丙酸 (5-ALA) 进行超声声动力疗法治疗软组织肉瘤
- 批准号:
19K18909 - 财政年份:2019
- 资助金额:
$ 53.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists